3/16
09:00 am
abvx
Abivax (ABVX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $160.00 price target on the stock.
Low
Report
Abivax (ABVX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $160.00 price target on the stock.
3/10
04:43 pm
abvx
Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year [Yahoo! Finance]
Medium
Report
Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year [Yahoo! Finance]
2/27
03:08 pm
abvx
2 Reasons Abivax Stock Could 10X by 2036 [Yahoo! Finance]
Low
Report
2 Reasons Abivax Stock Could 10X by 2036 [Yahoo! Finance]
2/25
08:03 am
abvx
Abivax (ABVX) had its "buy" rating reaffirmed by BTIG Research. They now have a $150.00 price target on the stock.
Low
Report
Abivax (ABVX) had its "buy" rating reaffirmed by BTIG Research. They now have a $150.00 price target on the stock.
2/24
07:18 am
abvx
Abivax (NASDAQ:ABVX) is now covered by analysts at Wedbush. They set an "underperform" rating on the stock.
Low
Report
Abivax (NASDAQ:ABVX) is now covered by analysts at Wedbush. They set an "underperform" rating on the stock.
2/21
06:00 am
abvx
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Low
Report
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
1/30
03:58 pm
abvx
Better Long-Term Buy: This Emerging Player or the Industry Leader? [Yahoo! Finance]
Neutral
Report
Better Long-Term Buy: This Emerging Player or the Industry Leader? [Yahoo! Finance]
1/19
04:18 pm
abvx
Prediction: This Healthcare Stock Could Soar by 72% in 2026 [Yahoo! Finance]
Low
Report
Prediction: This Healthcare Stock Could Soar by 72% in 2026 [Yahoo! Finance]
1/9
08:43 am
abvx
Abivax (NASDAQ:ABVX) had its price target raised by analysts at Morgan Stanley from $101.00 to $145.00. They now have an "overweight" rating on the stock.
Low
Report
Abivax (NASDAQ:ABVX) had its price target raised by analysts at Morgan Stanley from $101.00 to $145.00. They now have an "overweight" rating on the stock.
1/8
08:42 am
abvx
Abivax (NASDAQ:ABVX) was given a new $131.00 price target on by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Abivax (NASDAQ:ABVX) was given a new $131.00 price target on by analysts at Oppenheimer Holdings, Inc..
1/8
08:02 am
abvx
Abivax (NASDAQ:ABVX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
High
Report
Abivax (NASDAQ:ABVX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
1/8
07:17 am
abvx
Abivax (NASDAQ:ABVX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
Abivax (NASDAQ:ABVX) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/7
04:05 pm
abvx
Abivax Provides 2026 Corporate Outlook
Medium
Report
Abivax Provides 2026 Corporate Outlook
12/22
07:42 pm
abvx
Why Abivax Stock Was on Fire Today [Yahoo! Finance]
Low
Report
Why Abivax Stock Was on Fire Today [Yahoo! Finance]